ConductScience.org, home

Paper40211394

Natural killer cells: the immune frontline against circulating tumor cells.

Masmoudi D and 2 others. J Exp Clin Cancer Res, 2025. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Natural killer cells: the immune frontline against circulating tumor cells. Papers, record 40211394. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40211394

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural killer cells: the immune frontline against circulating tumor cells.
PubMed
Journal
J Exp Clin Cancer Res
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
10.29, provisional
iCite
Revised in PubMed
2025-04-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Masmoudi DDoryan
2Villalba MMartin
3Alix-Panabières CCatherine

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Killer Cells, NaturalMajor topic
Neoplastic Cells, CirculatingMajor topic
NeoplasmsMajor topic
Humans
Tumor Microenvironment
Animals
Tumor Escape

Source PubMed

Download CSV of topics

References199

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134824036Crosstalk between macrophages and natural killer cells in the tumor microenvironment.Int Immunopharmacol2021https://conductscience.org/library/papers/34824036PubMed
239403373Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy.Front Immunol2024https://conductscience.org/library/papers/39403373PubMed
334960234Neutrophil and Natural Killer Cell Interactions in Cancers: Dangerous Liaisons Instructing Immunosuppression and Angiogenesis.Vaccines (Basel)2021https://conductscience.org/library/papers/34960234PubMed
412913096Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule.J Exp Med2003https://conductscience.org/library/papers/12913096PubMed
530320350TGF-β1 secreted by M2 phenotype macrophages enhances the stemness and migration of glioma cells via the SMAD2/3 signalling pathway.Int J Mol Med2018https://conductscience.org/library/papers/30320350PubMed
611117911Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population.Lancet2000https://conductscience.org/library/papers/11117911PubMed
733681290CXCL10 is a Tumor Microenvironment and Immune Infiltration Related Prognostic Biomarker in Pancreatic Adenocarcinoma.Front Mol Biosci2021https://conductscience.org/library/papers/33681290PubMed
828592115Identification of chemokine CXCL10 in tumor microenvironment by antibody array as a prognostic marker in hepatocellular carcinoma.Neoplasma2017https://conductscience.org/library/papers/28592115PubMed
926873994Metabolic Reprogramming Supports IFN-γ Production by CD56bright NK Cells.J Immunol2016https://conductscience.org/library/papers/26873994PubMed
1036706761Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance.Cancer Cell2023https://conductscience.org/library/papers/36706761PubMed
1131799781Endogenous CXCL9 affects prognosis by regulating tumor-infiltrating natural killer cells in intrahepatic cholangiocarcinoma.Cancer Sci2020https://conductscience.org/library/papers/31799781PubMed
1232987138NK cells-directed therapies target circulating tumor cells and metastasis.Cancer Lett2021https://conductscience.org/library/papers/32987138PubMed
133342125Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma.Arch Otolaryngol Head Neck Surg1988https://conductscience.org/library/papers/3342125PubMed
1411489331The physiology of the lymphatic system.Adv Drug Deliv Rev2001https://conductscience.org/library/papers/11489331PubMed
1516230475CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.J Exp Med2005https://conductscience.org/library/papers/16230475PubMed
1621953496The role of melanoma tumor-derived nitric oxide in the tumor inflammatory microenvironment: its impact on the chemokine expression profile, including suppression of CXCL10.Int J Cancer2012https://conductscience.org/library/papers/21953496PubMed
1719738039Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity.Cancer Res2009https://conductscience.org/library/papers/19738039PubMed
187185419Role of natural killer cells in control of cancer metastasis.Cancer Metastasis Rev1982https://conductscience.org/library/papers/7185419PubMed
1927860528The Lymphatic System: Integral Roles in Immunity.Annu Rev Immunol2017https://conductscience.org/library/papers/27860528PubMed
2030137312The role of neutrophils in cancer.Br Med Bull2018https://conductscience.org/library/papers/30137312PubMed

See all 199 referencesDownload CSV of references

Cited by35

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
42921329Nanotechnology to Engineer the Surface of Immune Cells.ACS Nanosci Au2026https://conductscience.org/library/papers/42921329PubMed
42774839Blood-based tumor biomarkers: integrating biological layers and analytical strategies for precision cancer detection.Front Med (Lausanne)2026https://conductscience.org/library/papers/42774839PubMed
42704135Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells.Mol Pharm2026https://conductscience.org/library/papers/42704135PubMed
42535395CTGF: The remodeler of the tumor immune microenvironment (Review).Oncol Rep2026https://conductscience.org/library/papers/42535395PubMed
42506281Purinergic and Energy Metabolism Disruption in Oxidative Stress-Mediated Immunotoxicity Induced by Aflatoxin B1 and Fumonisin B1.J Fungi (Basel)2026https://conductscience.org/library/papers/42506281PubMed
42495619Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer.Front Immunol2026https://conductscience.org/library/papers/42495619PubMed
42342922Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.Cell Mol Immunol2026https://conductscience.org/library/papers/42342922PubMed
42332096Acquisition of Vimentin by trogocytosis inhibits the NK cell-mediated immune response against circulating tumour cells (CTCs).Cell Mol Immunol2026https://conductscience.org/library/papers/42332096PubMed
42280307Dual-Protein Intervention in CT26 Tumor-Bearing Mice: A Preliminary Evaluation of Its Effects on Anti-Tumor Efficacy of 5-Fluorouracil and Immune Responses.Nutrients2026https://conductscience.org/library/papers/42280307PubMed
42279367Risk of Malignancy with Immunosuppressive Drugs Used in Organ Transplants Compared to Those Used for Non-Transplant Indications.Cancers (Basel)2026https://conductscience.org/library/papers/42279367PubMed
42185071Triple-Negative Breast Cancer Cells Utilize IL8 and CXCL1 to Suppress NK Cells' Function and Facilitate Cancer Metastasis.Adv Sci (Weinh)2026https://conductscience.org/library/papers/42185071PubMed
42165861Overcoming resistance in CD44-overexpressing myeloma through combination therapy with ATRA, bortezomib, and NK cells.Cancer Immunol Immunother2026https://conductscience.org/library/papers/42165861PubMed
42161914Lactate metabolism and lactylation in cancer: from pathogenesis to therapeutic advances.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42161914PubMed
42125695Low prognostic nutritional index score is associated with lymph node metastasis in patients with breast cancer, whereas hemoglobin-albumin-lymphocyte-platelet score is not.Front Oncol2026https://conductscience.org/library/papers/42125695PubMed
42082461Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42082461PubMed
42001180Liquid biopsy reveals the immune status and protein profiles linked to CTC burden and clinical outcomes in metastatic breast cancer.J Exp Clin Cancer Res2026https://conductscience.org/library/papers/42001180PubMed
41952187Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategies.Exp Hematol Oncol2026https://conductscience.org/library/papers/41952187PubMed
41770372Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers.Ann Hematol2026https://conductscience.org/library/papers/41770372PubMed
41751962Do Metastatic Cells Arise from PD-L1+ Cell Niches in Gastric Adenocarcinoma?Int J Mol Sci2026https://conductscience.org/library/papers/41751962PubMed
41742461TNF-α deficiency underlies NK cell dysfunction in colorectal cancer.Oncoimmunology2026https://conductscience.org/library/papers/41742461PubMed

See all 35 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40211394

GET https://conductscience.org/api/papers/v1/40211394/references?page=2